At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 242 enrolled
Drug / intervention
Oxycodone +1 moredrug
Likely dose
Oxycodone 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparative Study of Immediate-Release Oxycodone Capsules Versus Immediate-Release Morphine Tablets for the Treatment of Chinese Patients With Cancer Pain.
In Brief
A Phase 3 clinical trial evaluating Oxycodone and Morphine for Cancer. Completed, enrolled 242 participants.
Detailed Summary
The efficacy of dose titration of OxyNorm™(Oxycodone) immediate-release capsules versus morphine immediate-release tablets in the treatment of cancer pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
Primary CompletionJun 2012
Study CompletionJul 2012
First PostedAug 2012
TodayJul 2026
First PostedAug 30, 2012
Enrollment StartJan 1, 2011
Primary CompletionJun 1, 2012
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 13.8 years ago
Interventions
Oxycodonedrug
dosage: 5mg, l0mg and 20mg dosage form: capsule frequency: every 6h, duration: 5-8 days
Morphinedrug
Morphine tablets 10mg and 20mg, oral every 4-6 hours